| This meeting was only intended for healthcare professionals from the UK and Ireland. This meeting was organised and funded by Teva UK Limited and included mention of Teva product(s). Prescribing information is available here. |
| Adverse events should be reported: Reporting forms and information can be found at www.mhra.gov.uk/yellowcard (UK) or www.hpra.ie (ROI). Adverse events should also be reported to Teva using the Reporting Side Effects Form or telephone +44 (0)207 540 7117, or email uk.safety@tevauk.com. |
Head Start Annual Meeting 2024
The sixth Head Start educational meeting focused on the latest advancements in headache and migraine management
We explored pertinent topics to gaining a deeper understanding of headache and migraine management strategies. Our esteemed multidisciplinary faculty shared their expertise, to bring attendees up to speed on the latest research.
Meeting Agenda
Day one explored the current treatment landscape and vision for the future.
-
A keynote session that delved into predictors of response to anti-CGRP monoclonal antibodies
-
The crucial role of patient empowerment in advocating for effective treatment
-
Immersive collaborative case studies, showcasing how an MDT can unite to optimise patient care
Day two aimed to elevate MDT strategies and introduce groundbreaking innovations through:
-
A lively panel discussion on enhancing patient care through service redesign
-
National experts unveiling cutting-edge treatments
-
Clinical case masterclasses on headaches and hormones and real-world treatment experiences of treatment holidays
A detailed agenda can be downloaded below
Download agendaHear more from Teva
Register your interest
To hear more from Teva about events and webinars, register your email
Sign upHighlights from 2022
Reflections from Head Start 2022
Held in March 2022 at the Birmingham Metropole Hotel, Head Start 2022 brought together healthcare professionals with an interest in headache and migraine.
Reflections from Head Start 2022
Held in March 2022 at the Birmingham Metropole Hotel, Head Start 2022 brought together healthcare professionals with an interest in headache and migraine.
Delegate Feedback
Head Start meetings have been rated highly by previous delegates
100% of delegates felt the meeting programme met their personal educational objectives*
84% of delegates rated the overall meeting in 2022 as "Excellent"*
100% of delegates would be interested in attending the future Head Start meetings*
Delegate feedback
Head Start Meeting 2022
All sessions were very good. I enjoyed the parrallel sessions. There were lots of take home messages.
Delegate feedback
Head Start 2022
It has given me a great learning experience
Delegate feedback
Head Start 2022
All the speakers were well informed and presented well
Hear more from Teva
Register your interest
To hear more from Teva about events and webinars, register your email
Sign up*of the number of delegates who completed event feedback
This meeting was open to HCPs from the UK and Ireland with an interest in headache and migraine. This promotional meeting was organised and funded by Teva UK Limited.
Registered in England No. 302461. Registered office: Teva UK Limited, Ridings Point, Whistler Drive, Castleford, West Yorkshire, WF10 5HX
+44 (0) 1977 628500 | www.tevauk.com | Copyright © 2024 Teva UK Limited
Adverse events should be reported: Reporting forms and information can be found at www.mhra.gov.uk/yellowcard (UK) or www.hpra.ie (ROI). Adverse events should also be reported to Teva using the Reporting Side Effects Form or telephone +44 (0) 207 540 7117, or email uk.safety@tevauk.com.
Privacy Policy | Pharmacovigilance Privacy Policy | Terms and Conditions | Accessibility | Reporting Adverse Events